Jack C Yalowich

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Cell Cycle Arrest

Induced Apoptosis

Top Venues

The Journal of pharmacology and experimental therapeutics

Molecular pharmacology

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Jessika Carvajal-Moreno, Xinyi Wang, Victor A Hernandez, Milon Mondal, Xinyu Zhao, Jack C Yalowich, Terry S Elton
Use of CRISPR/Cas9 with Homology-Directed Repair (HDR) to Gene-Edit Topoisomerase IIβ in Human Leukemia K562 Cells: Generation of a Resistance Phenotype . The Journal of pharmacology and experimental therapeutics (2024)
Jessika Carvajal-Moreno, Xinyi Wang, Victor A Hernandez, Milon Mondal, Xinyu Zhao, Jack C Yalowich, Terry S Elton
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II β in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Jessika Carvajal-Moreno, Xinyi Wang, Victor A Hernandez, Milon Mondal, Xinyu Zhao, Jack C Yalowich, Terry S Elton
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II β in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Jessika Carvajal-Moreno, Xinyi Wang, Victor A Hernandez, Milon Mondal, Xinyu Zhao, Jack C Yalowich, Terry S Elton
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II β in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase IIα Intron 19 Intronic Polyadenylation (IPA) in Acquired Etoposide Resistant Human Leukemia K562 Cells . Molecular pharmacology (2024)
Jessika Carvajal-Moreno, Xinyi Wang, Victor A Hernandez, Milon Mondal, Xinyu Zhao, Jack C Yalowich, Terry S Elton
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II β in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Jessika Carvajal-Moreno, Xinyi Wang, Victor A Hernandez, Milon Mondal, Xinyu Zhao, Jack C Yalowich, Terry S Elton
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II β in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Jessika Carvajal-Moreno, Xinyi Wang, Victor A Hernandez, Milon Mondal, Xinyu Zhao, Jack C Yalowich, Terry S Elton
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II β in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. The Journal of pharmacology and experimental therapeutics 389 (2) (2024)
Soziema E Dauda, Jessica A Collins, Jo Ann W Byl, Yanran Lu, Jack C Yalowich, Mark J Mitton-Fry, Neil Osheroff
Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks. International journal of molecular sciences 24 (15) (2023)
Chelsea A Mann, Jessika J Carvajal Moreno, Yanran Lu, Sheri Dellos-Nolan, Daniel J Wozniak, Jack C Yalowich, Mark J Mitton-Fry
Novel bacterial topoisomerase inhibitors: unique targeting activities of amide enzyme-binding motifs for tricyclic analogs. Antimicrobial agents and chemotherapy (2023)
Terry S Elton, Victor A Hernandez, Jessika Carvajal-Moreno, Xinyi Wang, Deborah Ipinmoroti, Jack C Yalowich
Intronic Polyadenylation in Acquired Cancer Drug Resistance Circumvented by Utilizing CRISPR/Cas9 with Homology-Directed Repair: The Tale of Human DNA Topoisomerase IIα. Cancers 14 (13) (2022)
Jessika Carvajal-Moreno, Victor A Hernandez, Xinyi Wang, Junan Li, Jack C Yalowich, Terry S Elton
Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIβ Expression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide . The Journal of pharmacology and experimental therapeutics (2022)